Product Pathways - MAPK Signaling
- Molecular Formula:
- Molecular Weight:
- 267.28 g/mol
Directions for Use
Supplied as a lyophilized yellow powder. For 20 mM stock, reconstitute 1.5 mg in 280 µl DMSO (5 mg in 933.3 μl). For 50 mM stock, reconstitute 1.5 mg in 112 µl DMSO (5 mg in 373.3 μl). Store in aliquots at -20ºC. See enclosed MSDS for further information. This product is for in vitro research use only and is not intended for use in humans or animals.
Top: SK-N-MC cells were pretreated with varying amounts of PD980559 for 1 hour, then treated with FGF for 30 minutes. Cell extracts were blotted with Phospho-p44/p42 MAP Kinase (Thr202/Tyr204) Antibody #9101. Middle: COS cells were transfected with pCMV-MKK3 for 22 hours, pretreated with varying amounts of PD98059 for 1 hour, then treated with anisomycin for 30 minutes. Cell extracts were blotted with Phospho-MKK3/MKK6 (Ser189/207) Antibody #9231. Lower: 293 cells were pretreated with varying amounts of PD98059 for 1 hour, then treated with sodium chloride for 30 minutes. Cell extracts were blotted with Phospho-SEK1/MKK4 (Thr261) Antibody #9151.
PD98059 is soluble in DMSO at 10-100 mM. For use with in vitro or cell-based assays, it may be diluted into aqueous buffers to yield desired concentrations (<100 µM) with final DMSO concentrations of ~0.1%. IC50 values for inhibitory activity against MEK1 are around 5-10 µM. For experiments with cultured cells, CST recommends pretreating with this inhibitor for one hour prior to stimulation.
MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.
PD98059 has been shown to act in vivo as a highly selective inhibitor of MEK1 activation and the MAP kinase cascade (1-4). PD98059 binds to the inactive forms of MEK1 and prevents activation by upstream activators such as c-Raf (3).
- Crews, C.M. et al. (1992) Science 258, 478-480.
- Alessi, D.R. et al. (1994) EMBO J. 13, 1610-1619.
- Rosen, L.B. et al. (1994) Neuron 12, 1207-1221.
- Cowley, S. et al. (1994) Cell 77, 841-852.
- Zhang, R. et al. (2011) PLoS One 6, e23831. Applications: Western Blotting
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 4370 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E) XP® Rabbit mAb
- 4376 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (20G11) Rabbit mAb
- 4377 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (197G2) Rabbit mAb
- 9101 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
- 9106 Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (E10) Mouse mAb
- 9800 p44/42 MAP Kinase Assay Kit (Nonradioactive)
- 9903 U0126
For Research Use Only. Not For Use In Diagnostic Procedures.